Adverse Event Rates Change Favorably Over Time for Patients Bridged With the HeartWare Left Ventricular Assist Device
Simon Maltais(Intermountain Healthcare), Robert L. Kormos(Abbott Northwestern Hospital), Katrin Leadley(Heartware International (United States)), Valluvan Jeevanandam(University of Chicago), Jeffrey J. Teuteberg(Stanford University), Samer S. Najjar(University of Tennessee Health Science Center), Edwin C. McGee(University of Chicago), Mark S. Slaughter(University of Louisville), Duc T. Pham(Northwestern Memorial Hospital), K. Aaronson(University of Michigan)
Cited by 12
Related Papers
Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults
|Circulation|2005|1.2k
Genome-wide association study identifies eight loci associated with blood pressure
|Nature Genetics|2009|1.2k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711